IP Verse

Opiant Pharmaceuticals competitive analysis

Loading summary...

Latest PTAB cases involving Opiant Pharmaceuticals

Discover the latest PTAB cases involving Opiant Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 9, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Opiant Pharmaceuticals

IPR2019-00685Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision
IPR2019-00686Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00687Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00688Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision
IPR2019-00689Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00690Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00691Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00692Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00693Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00694Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Opiant Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OPIANT PHARMACEUTICALS - - - 15
NALOX 1 PHARMACEUTICALS - - 15 -